Department of Research, Health Insurance Review & Assessment Service (HIRA), Wonju, Korea.
Department of Pediatrics, Korea University Ansan Hospital, Ansan, Korea.
J Korean Med Sci. 2024 Jul 29;39(29):e216. doi: 10.3346/jkms.2024.39.e216.
This study aimed to evaluate the differences in the baseline characteristics and patterns of antibiotic usage among hospitals based on their participation in the Korea National Antimicrobial Use Analysis System (KONAS). We obtained claims data from the National Health Insurance for inpatients admitted to all secondary- and tertiary-care hospitals between January 2020 and December 2021 in Korea. 15.9% (58/395) of hospitals were KONAS participants, among which the proportion of hospitals with > 900 beds (31.0% vs. 2.6%, < 0.001) and tertiary care (50.0% vs. 5.2%, < 0.001) was higher than that among non-participants. The consumption of antibiotics targeting antimicrobial-resistant gram positive bacteria (33.7 vs. 27.1 days of therapy [DOT]/1,000 patient-days, = 0.019) and antibiotics predominantly used for resistant gram-negative bacteria (4.8 vs. 3.7 DOT/1,000 patient-days, = 0.034) was higher in KONAS-participating versus -non-participating hospitals. The current KONAS data do not fully represent all secondary- and tertiary-care hospitals in Korea; thus, the KONAS results should be interpreted with caution.
本研究旨在评估基于参与韩国国家抗菌药物使用分析系统(KONAS)的医院在基线特征和抗生素使用模式方面的差异。我们从韩国全国医疗保险中获取了 2020 年 1 月至 2021 年 12 月期间所有二级和三级保健医院住院患者的索赔数据。395 家医院中有 15.9%(58/395)参与了 KONAS,其中,>900 张病床的医院比例(31.0%比 2.6%,<0.001)和三级保健(50.0%比 5.2%,<0.001)的比例高于非参与者。针对抗微生物耐药革兰阳性菌的抗生素的使用量(33.7 比 27.1 天治疗剂量/1000 患者天,=0.019)和主要用于耐药革兰阴性菌的抗生素的使用量(4.8 比 3.7 天治疗剂量/1000 患者天,=0.034)在 KONAS 参与医院中更高。目前的 KONAS 数据不能完全代表韩国所有的二级和三级保健医院;因此,应谨慎解读 KONAS 的结果。